Asia Pacific
-
Mainland-based Jacobio Pharmaceuticals has kicked off the roadshow for its Hong Kong listing. It is eyeing a valuation of up to HK$10.6bn ($1.37bn).
-
Crédit Agricole’s Benjamin Lamberg has been appointed as the bank’s new Taiwan chief executive officer, GlobalCapital Asia has learnt.
-
Credit Suisse has hired ex-UBS banker and former banking regulator Alan Wang as its chief operating officer for China.
-
GlobalCapital Asia has spent the last two months talking to banks and their clients to determine the most impressive capital markets transactions and advisers across Asia ex-Japan in 2020, a volatile and unpredictable year. We are pleased to begin our awards announcements in the loan market.
-
Too many Chinese investors focus on the originator more than the asset pool. That undermines one of the crucial purposes of securitization.
-
Chinese property developer Logan Group Co courted investors with a six year bond on Monday, raising $300m from a solid order book of $3.3bn.
-
Suzhou SND Group Co, a Chinese local government financing vehicle (LGFV), got lukewarm support for its debut dollar bond on Monday, forcing it to offer a bit of premium to get its deal past the finish line.
-
Chinese financial technology company Bairong is targeting Hong Kong for its IPO, having filed a draft prospectus with the city’s bourse.
-
Philippine company SMC Global Power Holdings Corp added $350m to its coffers from a bond tap on Monday, taking advantage of market stability to return to investors rapidly.
-
Yongcheng Coal and Electricity Group Co and Tsinghua Unigroup Co, which together have Rmb40bn ($6.1bn) of bonds outstanding in China’s domestic market, have told investors to expect more non-payments this month following a spate of recent defaults.
-
VPBank Finance Co, the consumer finance arm of Vietnam Prosperity Joint Stock Commercial Bank, has exercised the greenshoe option to increase the size of its loan to $170m.
-
Chinese electric vehicle manufacturer Xpeng is selling a chunk of new American Depository Shares (ADS) to fund research and development and further expansion.